Group A streptococci in the 1990s

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue TOPIC T1, 2000, Pages 3-12

  Efstratiou, Androulla ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT INHIBITOR; CYSTEINE PROTEINASE; EXOTOXIN; HYALURONIC ACID; HYALURONIDASE; M PROTEIN; PEPTIDASE; PROTEIN; STREPTOKINASE; STREPTOLYSIN O; STREPTOLYSIN S;

BACTERIAL VIRULENCE; CELL SURFACE; CONFERENCE PAPER; HUMAN; MULTIPLE ORGAN FAILURE; PATHOGENESIS; RHEUMATIC FEVER; SCARLET FEVER; SEPTIC SHOCK; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

EID: 0033973453     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.suppl_1.3     Document Type: Conference Paper

References (65)

1. Schellekens, J. F. P., Schouls, L. M., van Pelt, W., Esveld, H. & van Leevwen, W. J. (1998). Group A streptococci: a change in virulence? Netherlands Journal of Medicine 52, 209-17.
2. Christie, C. D. C., Havens, P. L. & Shapiro, E. D. (1988). Bacteremia with Group A streptococci in childhood. American Journal of Diseases of Childhood 142, 559-61.
3. Markowitz, M. (1994). Changing epidemiology of group A streptococcal infections. Pediatric Infectious Disease Journal 13, 557-60.
4. Holm, S. E. (1996). Invasive group A streptococcal infections. New England Journal of Medicine 335, 590-1.
5. Holm, S. E., Norrby, A., Bergholm, A. M. & Norgren, M. (1992). Aspects of pathogenesis of serious group A streptococcal infections in Sweden 1988-1989. Journal of Infectious Diseases 166, 31-7.
6. Schwartz, B., Facklam, R. R. & Elliott, J. A. (1994). Trends in group A streptococcal serotype distribution: the end of the M-type 1 epidemic in the US. In Pathogenic Streptococci: Present and Future, (Totolian, A., Ed.), pp. 3-5. Lancer Publications, St Petersburg.
7. Homer, C. & Shulman, S. T. (1991). Clinical aspects of acute rheumatic fever. Journal of Rheumatology 18, Suppl. 29, 2-13.
8. Kaplan, E. L., Johnson, D. R. & Cleary, P. P. (1989). Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. Journal of Infectious Diseases 159, 101-3.
9. Wannamaker, L. W. (1970). Differences between streptococcal infections of the throat and of the skin. New England Journal of Medicine 282, 23-31.
10. Wannamaker, L. W. (1970). Differences between streptococcal infections of the throat and of the skin. New England Journal of Medicine 282, 78-85.
11. O'Hern, E. (1975). Rebecca Craighill Lancefield, pioneer microbiologist. American Society for Microbiology News 41, 805-10.
12. Lancefield, R. C. (1933). A serological differentiation of human and other groups of hemolytic streptococci. Journal of Experimental Medicine 57, 571-95.
13. Lancefield, R. C. (1962). Current knowledge of type-specific M antigen of group A streptococci. Journal of Immunology 89, 307-13.
14. Griffith, F. (1934). The serological classification of Streptococcus pyogenes. Journal of Hygiene (Cambridge) 34, 542-84.
15. Colman, G., Efstratiou, A. & Gaworzewska, E. T. (1988). The pyogenic streptococci. Public Health Laboratory Service Microbiology Digest 5, 5-7.
16. Colman, G., Efstratiou, A. & Morrison, D. (1992). Streptococci and related organisms. In Identification Methods in Applied and Environmental Microbiology, (Board, R. G., Jones, D. & Skinner, F. A., Eds), pp. 221-49. Society for Applied Bacteriology Technical Series No. 29. Blackwell Scientific Publications, London.
17. Johnson, D. R., Kaplan, E. L., Sramek, J., Bicova, R., Havlicek, J., Havlickova, H. et al. (1996). Laboratory Diagnosis of Group A Streptococcal Infections. World Health Organization, Geneva.
18. Maxted, W. R., Widdowson, J. P., Fraser, C. A. M., Ball, L. C. & Bassett, D. C. J. (1973). The use of the serum opacity reaction in the typing of group A streptococci. Journal of Medical Microbiology 6, 83-90.
19. Facklam, R., Beall, B., Efstratiou, A., Fischetti, V., Johnson, D., Kaplan, E. et al. (1999). emm typing and validation of provisional M types for group A streptococci. Emerging Infectious Diseases 5, 247-53.
20. Beall, B., Facklam, R. & Thompson, T. (1996). Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. Journal of Clinical Microbiology 34, 953-8.
21. Hookey, J. V., Saunders, N. A., Clewley, J. P., Efstratiou, A. & George, R. C. (1996). Virulence regulon polymorphisms in group A streptococci revealed by long PCR: implications for epidemiological and evolutionary studies. Journal of Medical Microbiology 45, 285-93.
22. Kaufhold, A., Podbielski, A., Baumgarten, G., Blokpoel, M., Top, J. & Schouls, L. (1994). Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiology Letters 119, 19-25.
23. Stanley, J., Desai, M., Xerry, J., Tanna, A., Efstratiou, A. & George, R. C. (1996). High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks. Journal of Infectious Diseases 174, 500-6.
24. Gardiner, D. L., Goodfellow, A. M., Martin, D. R. & Sriprakash, K. S. (1998). Group A streptococcal Vir types are M-protein gene (emm) sequence type specific. Journal of Clinical Microbiology 36, 902-7.
25. Scott, J. R., Cleary, P., Caparon, M. G., Musser, J. M., Kehoe, M., Heden, L. et al. (1995). New name for the positive regulator of the M protein of group A streptococcus. Molecular Microbiology 17, 799.
26. Saunders, N. A., Hallas, G., Gaworzewska, E. T., Metherell, L., Efstratiou, A., Hookey, J. V. et al. (1997). PCR-enzyme linked immunoabsorbent assay and sequencing as an alternative to serology for M-antigen typing of Streptococcus pyogenes. Journal of Clinical Microbiology 35, 2689-91.
27. Musser, J. M., Hauser, A. R., Kim, M. H., Schlievert, P. M., Nelson, K. & Selander, R. K. (1991). Streptococcus pyogenes causing toxic shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proceedings of the National Academy of Sciences, USA 88, 2668-72.
28. Desai, M., Efstratiou, A., George, R. & Stanley, J. (1999). High-resolution genotyping of Streptococcus pyogenes serotype M1 isolates by fluorescent amplified-fragment length polymorphism analysis. Journal of Clinical Microbiology 37, 1948-52.
29. Fischetti, V. A. (1989). Streptococcal M protein: molecular design and biological behaviour. Clinical Microbiology Reviews 2, 285-314.
30. Stevens, D. L. (1997). The toxins of group A streptococcus, the flesh eating bacteria. Immunological Investigations 26, 129-50.
31. Alouf, J. E., Knoll, H. & Kohler, W. (1991). The family of mitogenic shock-inducing and superantigenic toxins from staphylococci and streptococci. In Source of Bacterial Proteins (Alouf, J. E. & Freer, J. H., Eds), pp. 367-14. Academic Press, San Diego, CA.
32. O'Connor, S. P. & Cleary, P. P. (1986). Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infection and Immunity 53, 432-4.
33. Reda, K. B., Kapur, V., Mollick, J. A., Lamphear, J. G., Musser, J. M. & Rich, R. R. (1994). Molecular characterization and phylogenetic distribution of the streptococcal superantigen (ssa) from Streptococcus pyogenes. Infection and Immunity 62, 1867-74.
34. Kehoe, M. A., Miller, L., Walker, J. A. & Boulnois, G. J. (1987). Nucleotide sequence of the streptolysin O (s/o) gene: structural homologies between Slo and other membrane damaging thiol-activated toxins. Infection and Immunity 55, 3228-32.
35. Wessels, M. R., Moses, A. E., Goldberg, J. B. & DiCesare, T. J. (1991). Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proceedings of the National Academy of Sciences, USA 88, 8317-21.
36. Hollingshead, S. K., Readdy, T., Arnold, J. & Bessen, D. E. (1994). Molecular evolution of a multi-gene family in group A streptococci. Molecular Biology and Evolution 11, 208-19.
37. Hollingshead, S. K., Readdy, T. L., Yung, D. L. & Bessen, D. E. (1993). Structural heterogeneity of the emm gene cluster in group A streptococci. Molecular Microbiology 8, 707-17.
38. Akesson, P., Sjoholm, A. G. & Bjorck, L. (1996). Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. Journal of Biological Chemistry 271, 1081-8.
39. Stevens, D. L. (1992). Invasive group A streptococcus infections. Clinical Infectious Diseases 14, 2-12.
40. Hoge, C. W., Schwartz, B., Talkington, D. F., Breiman, R. F., MacNeill, E. M. & Englender, S. J. (1993). The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. Journal of the American Medical Association 269, 384-9.
41. Hacker, J., Blum-Oehler, G., Mühldorfer, I. & Tschape, H. (1997). Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Molecular Microbiology 23, 1089-97.
42. Berge, A., Rasmussen, M. & Björk, L. (1997). Identification of an insertional sequence in a pathogenicity island of Streptococcus pyogenes. Thesis. Molecular analysis of Streptococcus pyogenes and its interactions with the human host, Lund, Sweden. ISBN 91-628-2719-7.
43. Kehoe, M. A., Kapur, V., Whatmore, A. M. & Musser, J. M. (1996). Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology. Trends in Microbiology 4, 436-43.
44. Whatmore, A. M. & Kehoe, M. A. (1994). Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in Vir regulon. Molecular Microbiology 11, 363-74.
45. Pancholi, V. & Fischetti, V. (1993). Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proceedings of the National Academy of Sciences, USA 90, 8154-8.
46. Chausee, M. S., Ajdic, D. & Ferretti, J. J. (1999). The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infection and Immunity 67, 1715-22.
47. Proft, T., Louise Moffatt, S., Berkahn, C. J. & Fraser, J. D. (1999). Identification and characterization of novel superantigens from Streptococcus pyogenes. Journal of Experimental Medicine 189, 89-102.
48. Hoe, N., Nakashima, K., Grigsby, D., Pan, X., Dou, S. J., Naidich, S. et al. (1999). Rapid molecular genetic subtyping of serotype M1 group A streptococcus strains. Emerging Infectious Diseases 5, 254-63.
49. Efstratiou, A., George, R. C., Gaworzewska, E. T., Hallas, G., Tanna, A., Blake, W. A. et al. (1997). Group A streptococccal invasive disease in England and Wales. Advances in Experimental Medicine and Biology 418, 207-10.
50. Cartwright, K., Logan, M., McNulty, C., Harrison, S., George, R., Efstratiou, A. et al. (1995). A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire. Epidemiology and Infection 115, 387-97.
51. Communicable Disease Surveillance Centre. (1994). Invasive group A streptococcal infections in Gloucestershire. Communicable Diseases Report, CDR Weekly 4, 97.
52. Davies, H. D., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A. et al. (1996). Invasive group A streptococcal infections in Ontario, Canada. New England Journal of Medicine 335, 547-54.
53. Eriksson, B. K., Andersson, J., Holm, S. E. & Norgren, M. (1998). Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clinical Infectious Diseases 27, 1428-36.
54. Zurawski, C. A., Bardsley, M., Beall, B., Elliott, J. A., Facklam, R., Schwartz, B. et al. (1998). Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clinical Infectious Diseases 27, 150-7.
55. Kiska, D. L., Thiede, B., Caracciolo, J., Jordan, M., Johnson, D., Kaplan, E. L. et al. (1997). Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. Journal of Infectious Diseases 176, 992-1000.
56. Cockerill, F. R., Thompson, R. L., Musser, J. M., Schlievert, P. M., Talbot, J., Holley, K. E. et al. (1998). Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clinical Infectious Diseases 26, 1448-58.
57. Kaul, R., McGeer, A., Low, D. E., Green, K. & Schwartz, B. (1997). Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario group A streptococcal study. American Journal of Medicine 103, 18-24.
58. Chiobotaru, P., Yagupsky, P., Fraser, D. & Dagan, R. (1997). Changing epidemiology of invasive Streptococcus pyogenes infections in southern Israel: differences between two ethnic population groups. Pediatric Infectious Disease Journal 16, 195-9.
59. Inagaki, Y., Konda, T., Murayama, S., Yamai, S., Matsushima, A., Gyobu, Y. et al. (1997). Serotyping of Streptococcus pyogenes isolated from common and severe invasive infections in Japan, 1990-5: implications of the T3 serotype strain-expansion in TSLS. The Working Group for Group A Streptococci in Japan. Epidemiology and Infection 119, 41-8.
60. Carapetis, J., Robins-Browne, R., Martin, D., Shelby-James, T. & Hogg, G. (1995). Increasing severity of severe group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-untypeable clone. Clinical Infectious Diseases 21, 1220-7.
61. Robain, M., Baron, S. & Goulet, V. (1995). Invasive group A streptococcal infections in France. Presse Medicine 24, 1255-6.
62. The Working Group on Prevention of Invasive Group A Streptococcal Infections. (1998). Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? Journal of the American Medical Association 279, 1206-10.
63. Stevens, D. L. (1995). Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infectious Diseases 1, 69-78.
64. Norrby-Teglund, A., Kaul, R., Low, D. E., McGeer, A., Newton, D. W. & Anderson, U. (1996). Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. Journal of Immunology 156, 3057-64.
65. Dale, J. B. (1999). Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 17, 193-200.